Rebecca Byam bought $20k of HCWB
Chief Financial Officer at HCW Biologics Inc.. 14,235 shares at an average of $1.41, traded May 22, 2026, filed May 27, 2026.
Score components
- +22RoleCFO
- 0Trade size$20k at market
- +6Relative to holdingsHoldings up 33%
- +8Price context65% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-025474, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 22, 2026 | POpen-market purchase Common Stock | +14,235 | $1.41 | $20k | 57,245 | May 27, 2026 |
| May 22, 2026 | POpen-market purchase Common Stock Purchase Warrantderivative | +14,235 | $0.00 | $0 | 18,466 | May 27, 2026 |
Related signals
Other insiders at HCW Biologics Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 48Moderate | HCW Biologics Inc. | Lee Flowers SVP of Business Development | $20k 7,736 shares | +810% | |
| 49Moderate | HCW Biologics Inc. | Scott T Garrett director | $20k 7,736 shares | +23% | |
| 66Notable | HCW Biologics Inc. | Hing C Wong Chief Executive Officer | $60k 23,210 shares | +23% | |
| 61Notable | HCW Biologics Inc. | Scott T Garrett director | $250k 177,936 shares | +698% | |
| 65Notable | HCW Biologics Inc. | Hing C Wong Chief Executive Officer | $160k 113,879 shares | +23% | |
| 55Moderate | HCW Biologics Inc. | Scott T Garrett director | $100k 13,423 shares | +111% | |
| 41Moderate | HCW Biologics Inc. | Gary M Winer director | $9,998 1,342 shares | +49% | |
| 52Moderate | HCW Biologics Inc. | Hing C Wong Chief Executive Officer | $60k 8,054 shares | +2% | |
| 55Moderate | HCW Biologics Inc. | Rebecca Byam Chief Financial Officer | $220k 8,462 shares | +24% | |
| 41Moderate | HCW Biologics Inc. | Lee Flowers SVP of Business Development | $25k 962 shares | +20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.